Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Submitted by
admin
on December 1, 2014 - 11:31am
Source:
Seeking Alpha
News Tags:
Exelixis
prostate cancer
cabozantinib
Headline:
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Do Not Allow Advertisers to Use My Personal information
